These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 15601469

  • 1. Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin.
    Ravizza R, Gariboldi MB, Passarelli L, Monti E.
    BMC Cancer; 2004 Dec 15; 4():92. PubMed ID: 15601469
    [Abstract] [Full Text] [Related]

  • 2. miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells.
    Shi X, Valizadeh A, Mir SM, Asemi Z, Karimian A, Majidina M, Safa A, Yosefi B.
    Eur J Pharmacol; 2020 Aug 05; 880():173138. PubMed ID: 32416187
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Targeted cytotoxic somatostatin analogue AN-238 inhibits somatostatin receptor-positive experimental colon cancers independently of their p53 status.
    Szepeshazi K, Schally AV, Halmos G, Armatis P, Hebert F, Sun B, Feil A, Kiaris H, Nagy A.
    Cancer Res; 2002 Feb 01; 62(3):781-8. PubMed ID: 11830533
    [Abstract] [Full Text] [Related]

  • 5. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents.
    Mahyar-Roemer M, Roemer K.
    Oncogene; 2001 Jun 07; 20(26):3387-98. PubMed ID: 11423989
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cytoplasmic p21 induced by p65 prevents doxorubicin-induced cell death in pancreatic carcinoma cell line.
    Zhou Y, Li G, Ji Y, Liu C, Zhu J, Lu Y.
    J Biomed Sci; 2012 Feb 04; 19(1):15. PubMed ID: 22305266
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21.
    El-Khatib M, Geara F, Haddadin MJ, Gali-Muhtasib H.
    Radiat Oncol; 2010 Nov 15; 5():107. PubMed ID: 21078189
    [Abstract] [Full Text] [Related]

  • 10. p53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells.
    Aneja R, Ghaleb AM, Zhou J, Yang VW, Joshi HC.
    Cancer Res; 2007 Apr 15; 67(8):3862-70. PubMed ID: 17440101
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. HCT116 cells deficient in p21(Waf1) are hypersensitive to tyrosine kinase inhibitors and adriamycin through a mechanism unrelated to p21 and dependent on p53.
    Ferrandiz N, Martin-Perez J, Blanco R, Donertas D, Weber A, Eilers M, Dotto P, Delgado MD, Leon J.
    DNA Repair (Amst); 2009 Mar 01; 8(3):390-9. PubMed ID: 19150257
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. TNF-alpha promotes Doxorubicin-induced cell apoptosis and anti-cancer effect through downregulation of p21 in p53-deficient tumor cells.
    Cao W, Chi WH, Wang J, Tang JJ, Lu YJ.
    Biochem Biophys Res Commun; 2005 May 20; 330(4):1034-40. PubMed ID: 15823547
    [Abstract] [Full Text] [Related]

  • 15. Differential response of p53 and p21 on HDAC inhibitor-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo.
    Zopf S, Neureiter D, Bouralexis S, Abt T, Glaser KB, Okamoto K, Ganslmayer M, Hahn EG, Herold C, Ocker M.
    Int J Oncol; 2007 Dec 20; 31(6):1391-402. PubMed ID: 17982666
    [Abstract] [Full Text] [Related]

  • 16. The nitroxide Tempol modulates anthracycline resistance in breast cancer cells.
    Gariboldi MB, Terni F, Ravizza R, Meschini S, Marra M, Condello M, Arancia G, Monti E.
    Free Radic Biol Med; 2006 Apr 15; 40(8):1409-18. PubMed ID: 16631531
    [Abstract] [Full Text] [Related]

  • 17. Role of p21 as a determinant of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl] diamantane response in human HCT-116 colon carcinoma cells.
    Wang JJ, Hung HF, Huang ML, Lee HJ, Chern YT, Chang YF, Chi CW, Hsu YC.
    Oncol Rep; 2012 Feb 15; 27(2):529-34. PubMed ID: 22076474
    [Abstract] [Full Text] [Related]

  • 18. p53-Dependent activation of a molecular beacon in tumor cells following exposure to doxorubicin chemotherapy.
    Shah R, El-Deiry WS.
    Cancer Biol Ther; 2004 Sep 15; 3(9):871-5. PubMed ID: 15254427
    [Abstract] [Full Text] [Related]

  • 19. The antitumor effect of a novel differentiation inducer, 2, 2-Bis (4-(4-amino-3-hydroxyphenoxy) phenyl) adamantane (DPA), in combinatory therapy on human colon cancer.
    Wang JJ, Lee JY, Chen YC, Chern YT, Chi CW.
    Int J Oncol; 2006 Apr 15; 28(4):1003-12. PubMed ID: 16525652
    [Abstract] [Full Text] [Related]

  • 20. The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines.
    Bajbouj K, Schulze-Luehrmann J, Diermeier S, Amin A, Schneider-Stock R.
    BMC Complement Altern Med; 2012 May 28; 12():69. PubMed ID: 22640402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.